Medications

FDA adds new heart warning to Sanofi's Multaq

Federal health officials have added new safety warnings to the heart rhythm drug Multaq after company studies linked the pill to higher rates of heart attack, stroke and death in a subset of patients.

Cardiology

How to prevent recurrent stroke when the cause is unknown

Nearly one-third of patients with a stroke of unknown cause have a heart rhythm disorder that can be treated to prevent another stroke. That's the finding of the NOR-FIB study presented at EHRA 2022, a scientific congress ...

page 9 from 12